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INTRODUCTION
Hundreds of lipid species occur in the skin epidermis, 
where they constitute structural components, maintain cuta-
neous physiology, and participate in the progression of diseas-
es (Kendall et al., 2015). In particular, ceramides and free fatty 
acids (FFAs) are known to be pivotal to the skin barrier func-
tion (Joo et al., 2010; Park et al., 2012; Breiden and Sandhoff, 
2014), immune regulation, and inflammation (Kendall and 
Nicolaou, 2013; Uchida, 2014). FFAs display carbon chains of 
widely varying lengths (Joo et al., 2015), and a huge diversity 
of ceramides, as many as 342 species in 11 families created 
by the variety of constituting sphingoid bases and linked FFAs, 
are known to exist in the skin epidermis (Masukawa et al., 
2008; Rabionet et al., 2014). 
Alterations in ceramides and FFAs are closely associated 
with the pathophysiology of various dermatoses (Ishikawa et 
al., 2010; Janssens et al., 2012; van Smeden et al., 2014; Ohno 
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Patients with diabetes mellitus (DM) often suffer from diverse skin disorders, which might be attributable to skin barrier dysfunc-
tion. To explore the role of lipid alterations in the epidermis in DM skin disorders, we quantitated 49 lipids (34 ceramides, 14 free 
fatty acids (FFAs), and cholesterol) in the skin epidermis, liver, and kidneys of db/db mice, a Type 2 DM model, using UPLC-MS/
MS. The expression of genes involved in lipid synthesis was also evaluated. With the full establishment of hyperglycemia at the 
age of 20 weeks, remarkable lipid enrichment was noted in the skin of the db/db mice, especially at the epidermis and subcutane-
ous fat bed. Prominent increases in the ceramides and FFAs (>3 fold) with short or medium chains (<C26) occurred in the skin 
epidermis (16NS, 18NS, 24NS, 16NDS, 18NDS, 20NDS, 22NDS, 24NDS, C16:1FA, C18:2FA, and C18:1FA) and the liver (16NS, 
18NS, 20NS, 24:1NS, 18NDS, 20NDS, 22NDS, C16:1FA, C18:2FA, C18:1FA), whereas those with very long chains were not 
affected. In the kidney, only slight increases (<3 fold) were observed for 16NS, 18NS, 20NS, 26NDS, C26FA, and C22:1FA. Con-
sistently, LXRα/β and PPARγ, nuclear receptors promoting lipid synthesis, lipid synthesis enzymes such as elongases 1, 4, and 6, 
and fatty acid synthase and stearoyl-CoA desaturase were highly expressed in the skin and livers of the db/db mice. Collectively, 
our study demonstrates an extensive alteration in the skin and systemic lipid profiles of db/db mice, which could contribute to the 
development of skin disorders in DM.
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et al., 2015). Many efforts have been made to understand the 
implications of alterations in ceramides (Tawada et al., 2014) 
and FFAs (van Smeden et al., 2014) for skin diseases and to 
elucidate the mechanisms underlying those changes (Danso 
et al., 2017). Lines of evidence indicate that the depletion of 
long-, or very long–chained ceramides and FFAs is linked with 
impaired skin barrier function (van Smeden et al., 2014; Joo 
et al., 2015) and that supplementation with ceramides can im-
prove epidermal homeostasis (Simpson et al., 2014; Morifuji 
et al., 2015; Shiba et al., 2017). It was also found that the en-
zymes required to synthesize long-chained FFAs (elongases 
(ELOVL1, ELOVL4 and ELOVL6)), acylate long FFAs to sphin-
goid bases [CER synthase 3 (CerS3)], and produce unsatu-
rated FFAs [stearoyl CoA desaturase (SCD)], are altered in 
atopic dermatitis (Park et al., 2012; Danso et al., 2017). In the 
same vein, nuclear receptors governing lipid metabolism and 
synthesis, such as the liver X receptor (LXR) (Fowler et al., 
2003) and peroxisome proliferator-activated receptor (PPAR) 
(Hatano et al., 2010) are also involved in the epidermal barrier 
function and homeostasis (Schmuth et al., 2014).
In diabetes mellitus (DM), which causes profound and 
broad changes in energy metabolism and dyslipidemia (Ku-
mar et al., 2013; Sas et al., 2016), various skin disorders 
occur frequently, with a prevalence reaching ~80%, includ-
ing skin xerosis, itch, infection, and impaired wound healing 
(Demirseren et al., 2014; Macedo et al., 2016). Severe forms 
of diabetic dermopathy also occur, including bullosis diabeti-
corum, necrobiosis lipoidica diabeticorum, and scleredema 
diabeticorum (Yosipovitch et al., 1998; Quondamatteo, 2014). 
The frequent occurrence of skin disorders in DM has been 
explained as an abnormal proliferation and differentiation of 
keratinocytes and resultant impairment of the skin barrier 
function (Okano et al., 2016). An altered landscape of the skin 
lipidome has also been suggested to cause the skin disorders 
of DM (Sakai et al., 2003, 2005; Park et al., 2011). However, 
the detailed speciation of the ceramides and FFAs altered by 
DM and their implications for abnormal skin conditions remain 
largely unexplored.
Here, we examine the epidermal lipids of db/db mice at 20 
weeks of age, which represent Type 2 DM with long-standing 
hyperglycemia (Quondamatteo, 2014). We used sensitive 
ultra-performance liquid chromatography tandem mass spec-
trometry (UPLC-MS/MS) to quantitate 34 ceramides (CER-
NP (non-hydroxy fatty acid conjugated to phytosphingosine), 
CER-NDS (non-hydroxy fatty acid conjugated to dihydro-
sphingosine), CER-NS (non-hydroxy fatty acid conjugated to 
sphingosine), and CER-AP (α-hydroxy fatty acid conjugated 
to phytosphingosine) with varying carbon chain lengths), 14 
FFAs (C12, C14, C16, C16:1, C18, C18:1, C18:2, C20, C22, 
C22:1, C24, C24:1, C26, and C28) and cholesterol (CHOL) 
in the skin epidermis of db/db mice compared to their normal 
littermates, db/m mice. In addition, to explore the relationship 
between the skin and body lipidomes, we examined liver and 
kidney lipid profiles, the organs most affected by DM. We 
used principal component analysis (PCA), a metabolomics 
tool widely used to identify novel biomarkers (Joo et al., 2016; 
Jang et al., 2018), to identify global alterations in the lipid pro-
file in DM and to find lipid markers characteristic of DM.
MATERIALS AND METHODS
Materials
An AccQ•Tag Ultra derivatization kit (borate buffer and re-
agent) and AccQ•Tag Ultra eluents A and B were obtained 
from Waters (Milford, MA, USA). Ammonium formate, formic 
acid, and potassium hydroxide were acquired from Sigma-
Aldrich (St. Louis, MO, USA). Hydrochloric acid solution and 
sodium hydroxide were purchased from Daejung (Seoul, 
Korea). HPLC-grade methanol, ethyl acetate, isopropyl alco-
hol, and chloroform were purchased from Burdick & Jackson 
(Muskegon, MI, USA). CHOL and the FFAs (C12, C14, C16, 
C16:1, C18, C18:1, C18:2, C20, C22, C22:1, C24, C24:1, 
C26, and C28) were obtained from Sigma-Aldrich. Deuterated 
FFAs C16-D3, C20-D3, and C18:1-D2 were purchased from 
Cambridge Isotope Laboratories (Andover, MA, USA). Syn-
thetic CER-NP, CER-NDS, and CER-NS were purchased from 
Avanti Polar Lipids (Alabaster, AL, USA). Synthetic CER-AP 
was kindly provided by Evonik (Essen, Germany). 2,2’-dithio-
dipyridin, 2-picolylamine, and triphenylphosphine were pur-
chased from Sigma-Aldrich. All other reagents used were of 
the highest grade available. The water used was ultra-pure 
deionized water (18.2 MΩ•cm) produced using a Milli-Q Gradi-
ent system (Millipore, Bedford, MA, USA).
Animal experiments
C57BLKS/J-db/db and age-matched control C57BLKS/J-
m+/db mice (five-week-old males, Japan SLC Inc., Hama-
matsu, Japan) were housed in a room maintained at 22 ± 2°C 
with a 12 h dark/12 h light cycle. All animal experiments were 
conducted according to the Institutional Animal Care and Use 
Committee of the Ewha Laboratory Animal Genomics Center 
(IACUC-14-109). Mice were given free access to standard ro-
dent pellets (Purina, Seongnam, Korea). Body weight, fasting 
blood glucose concentration, and HbA1c level were measured 
at 8, 14, and 20 weeks. Blood was withdrawn from the cervi-
cal vein at the indicated time points; the blood hemoglobin 
A1c (HbA1c) level was determined using a DCA2000 HbA1c 
reagent kit (SIEMENS Healthcare Diagnostics, Inc., Tarry-
town, NY, USA), and blood glucose was measured using a 
glucometer (OneTouch Ultra, Johnson & Johnson Co., CA, 
USA). The moisture and trans-epidermal water loss (TEWL) of 
each group was measured at the end of the experiments (20 
weeks) with a MoistureMeterSC and Vapometer (Delfin Tech-
nology, Kuopio, Finland), respectively, after removing hair with 
an electrical shaver. Liver and skin samples were collected 
after sacrifice with CO2.
Histology and tissue sampling
For the histological examination of the skin, 7 mm×1 cm 
full-thickness skin was excised from the dorsum near the tail 
and stitched to filter paper before fixing in 10% formalin. For 
the oil red O staining, skin samples were freshly collected and 
immediately frozen in Optimal Cutting Temperature (OCT) 
compound (Tissue TEK®, Sakura Finetek, Tokyo, Japan). Fro-
zen sections were made 8 μm in thickness using a cryostat. 
Slides were fixed in 70% ethyl-alcohol and then placed in pro-
pylene glycol for 5 min. After that, the slides were incubated 
in 0.7% oil red O (Sigma-Aldrich) solution for 7 min at 60°C. 
Slides were rinsed with 85% propylene glycol for 3 min and 
then rinsed with distilled water. Counterstaining was done with 
Mayer’s hematoxylin for 5 min, and then the slides were rinsed 
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thoroughly in tap water. Slides were mounted in warmed glyc-
erin jelly solution. 
To examine the immunohistochemistry of ceramide, par-
affin-embedded skin sections were de-paraffinized and se-
quentially rehydrated. Antigen retrieval was performed using 
ph6.0 Target Retrieval solution (DAKO, Glostrup, Denmark) in 
a pressure cooker for 15 min. After cooling on ice for at least 
1 h, sections were incubated in 3% H2O2 for 30 min to block 
endogenous peroxidase. Sections were washed twice with 
PBS and blocked with a Mouse on Mouse (M.O.M.) kit (Vector 
Laboratories, Burlingame, CA, USA) overnight at 4°C followed 
by a protein block (DAKO) for 1 h at room temperature. Then, 
sections were incubated with anti-ceramide antibody (1:1000, 
Enzo, Farmingdale, NY, USA) overnight at 4°C. After 3 wash-
es in PBS, sections were incubated in horseradish peroxi-
dase (HRP)-conjugated secondary mouse antibody (DAKO) 
for 15 min at room temperature. For immunohistochemistry 
experiments, diaminobenzidine (DAB) (DAKO) was used for 
antibody development, and Mayer’s hematoxylin (DAKO) was 
used for counter staining.
To prepare the epidermal sheet for lipid sampling, the skin 
was disinfected with povidone and treated in 0.25% EDTA-
free trypsin for digestion overnight. The dermis was removed 
with tweezers to collect the epidermis. To prepare the liver tis-
sue sample, the liver was perfused with PBS, and 100 mg tis-
sue was collected from the same lobe in each animal. For the 
kidney samples, about 50 mg of kidney cortex was collected.
Analysis of lipids
Lipid extraction and sample preparation: Epidermal sheets 
or tissues were minced into small pieces in ice-cold 0.1% am-
monium acetate followed by homogenization in a Precellys 24 
(6500 rpm 1×30s, Bertin Instrument, Montigny-le-Bretonneux, 
France). Methanol (1.5 mL) was added to a 200 μL sample 
aliquot, which was placed into a glass tube with a Teflon-lined 
cap, and the tube was vortexed. Then, 5 mL of methyl-tert-
butyl ether (MTBE) was added, and the mixture was incubated 
for 1 h at room temperature in a shaker. Phase separation was 
induced by adding 1.25 mL of MS-grade water. After 10 min of 
incubation at room temperature, the sample was centrifuged 
at 1,000 g for 10 min. The top 4 mL (organic phase) was col-
lected. The solvent was volatilized using a Speedvac (EZ-2 
Plus, Genevac, Ipswich, UK). Each 4 mL of the filtrate was 
united and evaporated to dryness using a Speedvac at 40°C. 
The residues (extractable lipids) were reconstituted in 500 μL 
of chloroform–methanol 2:1 (v/v) for analysis by UPLC-MS/
MS. A standard stock solution of individual lipids (ca. 1 mg/
mL) was prepared by dissolving specific amounts of authentic 
standards in chloroform-methanol (1:1, v/v) and then storing 
it at –20°C. The working standard solutions of the lipid mix-
tures were serially diluted with chloroform-methanol (2:1, v/v) 
to obtain the concentrations needed for calibration curve stan-
dards. FFAs were quantified through derivatization according 
to a method previously described (Joo et al., 2013).
UPLC-MS/MS: The chromatographic separation was carried 
out using an ACQUITY UPLC system (Waters, Manchester, 
UK) equipped with an ACQUITY UPLC BEH C18 column (1.7 
μm, 2.1×50 mm). The column temperature and autosampler 
tray temperature were maintained at 55°C and 4°C, respec-
tively. The mobile phase for the CER (CER-NDS, CER-NS, 
CER-AP, CER-NP) and FFA analyses consisted of methanol: 
water=1:1 (v/v, 2 mM ammonium formate and 0.1% formic 
acid, solvent A) and methanol: isopropyl alcohol=6:4 (v/v, 2 
mM ammonium formate and 0.1% formic acid, solvent B). 
Gradient elution was initiated with 20% B (50% B for the CER 
analysis) for 0.5 min and changed to 100% B in 2 min. The 
isocratic elution with 100% B was kept for 5 min and then re-
turned to 20% B (50% B for CERs analysis) in 6.5 min. The 
total run time was 6.5 min. The flow rate was 0.3 mL/min, and 
the injection volume was 2 μL. 
The UPLC-MS/MS analysis was performed using a Waters 
Micromass Quattro Premier XE triple quadrupole mass spec-
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Fig. 1. Macroscopic and functional skin assessment of db/db & db/m mice. (A) Appearance of db/m and db/db mice at 20 weeks of age. 
The (B) body weight, (C) blood glucose, and (D) HbAc1 of the db/db mice. (E) Moisture and TEWL of db/m and db/db mice. Values are the 
mean ± SE of 5-10 animals. ** indicates a statistically significant difference from db/m (control) (Student’s t-test, p<0.05, **p<0.01).
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trometer. The ESI-MS spectra were acquired in the positive 
ion multiple reaction monitoring (MRM) mode with a capillary 
voltage of 3.5 kV, source temperature of 120°C, desolvation 
temperature of 350°C, desolvation gas flow rate of 750 L/h, 
and cone gas flow rate of 50 L/h. The optimum cone voltages 
for the FFAs and CERs were set to 20 and 25 eV, respec-
tively. The collision energy for the MRM mode was optimized 
for each analyte. 
The cholesterol analysis was performed with a gradient elu-
tion of water (solvent A) and acetonitrile (solvent B). The gradi-
ent elution was initiated with 85% B for 0.5 min and changed 
to 100% B in 1.5 min. The isocratic elution with 100% B was 
kept for 3.5 min and then returned to 85% B in 5.0 min. The 
flow rate was 0.4 mL/min, and the injection volume was 2 μL. 
The APCI-MS spectra were acquired in positive ion mode 
with an APCI corona current of 4.0 mA, a source temperature 
of 120°C, desolvation temperature of 400°C, and desolvation 
gas flow rate of 500 L/h. The optimum cone voltage was 35 
V. The collision energy for the MRM mode was optimized to 6 
eV (m/z 369.2>369.2). We controlled the data acquisition and 
process with a MassLynx Version 4.1 (Waters).
RNA isolation
Liver and skin samples were lysed using Trizol (Invitrogen, 
CA, USA). After the addition of chloroform, samples were cen-
trifuged at 12,000 rpm for 10 min. The aqueous phase was 
mixed with isopropanol, and RNA pellets were collected by 
centrifugation (12,000 rpm, 15 min, 4°C). The RNA pellets 
were washed with 70% ethanol and dissolved in RNase-free, 
DEPC (diethyl pyrocarbonate)-treated water (Waltham, MA, 
USA). The RNA yield was estimated by determining the optical 
density at 260 nm with a NanoDrop 1000 spectrophotometer 
(NanoDrop Technologies, INC., Wilmington, DE, USA).
Real-time PCR
The relative mRNA expression levels were measured using 
quantitative real-time PCR. cDNA was synthesized from 1250 
ng of total RNA with oligo (dT) (Bioelpis, Seoul, Korea). SYBR 
Green PCR master mix and a StepOnePlusTM real-time PCR 
machine (Applied Biosystems, Warrington, UK) were used 
in each reaction. The sequence of primers was as follows: 
forward LXRα, 5′-ACT TTG CCA AAC AGC TCC CT-3′; re-
verse LXRα, 5′- AAG GTG ATG CTC TCA CTG CC-3′; forward 
LXRβ, 5′-TGG ACG ATG CAG AGT ATG CC-3′; reverse LXRβ, 
5′-TCC TCG TGT AGG AGA GGA GC-3′; forward PPARγ, 5′-
TGA ACG TGA AGC CCA TCG AG-3′; reverse PPARγ, 5′-CGA 
TCT GCC TGA GGT CTG TC-3′; forward Elovl6, 5′-CTG GAT 
GCA GCA TGA CAA CG-3′; reverse Elovl6, 5′-GCC GAT GTA 
GGC CTC AAA GA-3′; forward Elovl1, 5′-TAC CCC ATC ATC 
ATC CAC CT-3′; reverse Elovl1, 5′-GGA GCT CCA TTT TGC 
TGA AC-3′; forward Elovl4, 5′-GTC TCT CTA CAC CGA CTG 
CC-3′; reverse Elovl4, 5′-CCG GTT TTT GAC TGC TTC GG-
3′; forward FAS, 5′-AGC TAC CGG GCA AAG ATG AC-3′; re-
verse FAS, 5′-CCC GAT CTT CCA GGC TCT TC-3′; forward 
SCD, 5′-AGC CTG TTC GTT AGC ACC TT-3′; reverse SCD, 
5′-CCA GGA TAT TCT CCC GGG ATT G-3’. Cycling param-
eters were 51°C for 2 min, 95°C for 10 min, 40 cycles of 95°C 
for 15 s, and 51°C for 1 min.
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Fig. 2. Histological appearance of the skin of db/db and db/m mice. (A) H&E and (B) oil-red O staining of the skin of db/db and db/m mice. (C) 
Immunohistochemical staining for ceramides in the skin of db/db and db/m mice. Red arrows indicate a representative signal for ceramides 
in the stratum corneum of db/m and db/db mice.
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Statistical analysis 
Data are presented as the mean ± SD. PCA for the lipid 
profiles were done using SIMCA-P+ (v12.0 version, Umetrics, 
Umea, Sweden). Data were analyzed by Student’s t-test to 
identify statistically significant differences from the control 
group. Significance was acknowledged when p<0.05. 
RESULTS
Reduced skin hydration, trans-epidermal water loss, and 
altered skin lipid profiles in db/db mice, a Type 2 diabetes 
mellitus model
DM was well-established in the db/db mice from the age of 
14 weeks, as determined by high body weights (Fig. 1A, 1B), 
evident hyperglycemia (Fig. 1C), and significantly increased 
levels of hemoglobin A1c (HbAc1) (Fig. 1D). At the age of 20 
weeks, HbAc1 was 2.6 fold higher than in the db/m mice, and 
blood glucose exceeded the control by >3.0 fold, reflecting 
a chronic stage of severe hyperglycemia. At 20 weeks, skin 
moisture and TEWL were significantly lower in the db/db mice 
than in the db/m mice (Fig. 1E), suggesting the impairment 
of epidermal homeostasis. Histological examination revealed 
that the skin of the db/db mice was markedly thickened (Fig. 
2A), which was largely attributable to an increased subcutane-
ous fat bed. In contrast, the epidermis and dermis of the db/
db mice was rather compressed and had a flaky appearance. 
Lipid-specific oil-red O staining of the skin suggested a pro-
found increase in the lipids in the epidermis and subcutis of 
the db/db mice (Fig. 2B). The immunohistochemical analysis 
of ceramide using ceramide-specific antibody revealed that 
the distribution and content of ceramides were also substan-
tially altered in the skin epidermis of the db/db mice (Fig. 2C).
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Fig. 3. Ceramides and free fatty acids in the skin, liver, and kidneys of db/db mice compared to db/m mice. (A) Cholesterol-normalized lipid 
abundance in the skin epidermis of db/db mice (as fold of that in db/m mice). Protein-normalized lipids in the (B) liver and (C) kidney. Values 
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Higher levels of medium-chained ceramides and FFAs in 
the skin epidermis, liver, and kidneys of the db/db mice
Ceramides, FFAs, and CHOL constitute the major skin epi-
dermal lipid classes. Their composition significantly affects 
epidermal homeostasis, and their alteration is closely linked 
with skin diseases (Li et al., 2016). The quantitation of cerami-
des, saturated and unsaturated FFAs, and CHOL in the skin 
epidermis, the liver, and the kidneys revealed that most ce-
ramides and FFAs were significantly higher in the db/db mice 
than in the db/m mice (Fig. 3A-3C). These patterns became 
evident and statistically significant when the skin lipids were 
normalized with CHOL (Joo et al., 2015) and those of the liver 
and kidney with protein content. Specifically, ceramides with 
medium-length chains (16NS, 18NS, 18NDS, 20NDS, and 
22NDS), and unsaturated C18 FFAs (C18:2FA and C18:1FA) 
were ≥3 fold higher in the skin epidermis, whereas in the liv-
er, 16NS, 18NS, 20NS, 18NDS, 20NDS, C16:1FA, C18:2FA, 
and C18:1FA were higher (Fig. 3A, 3B). The alteration in the 
amount of ceramides and FFAs was markedly attenuated in 
the kidney, but similarly, 16NS, 18NS, 26NDS, and C26FA 
were more plentiful in the db/db mice than in the db/m mice. 
The PCA for the lipid changes further indicated that db/db mice 
could be differentiated from db/m by the lipids in their skin and 
liver (Fig. 4A, 4B) and to a lesser extent their kidney (Fig. 4C). 
Loading plots drawn in ascending order revealed that 16NS, 
22NDS, 24NS, and 18NS were the key differentiators of db/
db vs. db/m mice in the skin epidermis, whereas in the liver, 
20NS, C18:2FA, 22NDS, and 16NS were distinctive (Fig. 4D, 
4E). In the kidney, the variations in loadings (i.e., confidence 
interval) was large (Fig. 4F), indicating that the differences in 
the lipid content between db/db and db/m mice were minute. 
Increased gene expression involved in lipid synthesis in 
the liver and skin of db/db mice
To investigate the mechanism underlying the alteration of 
epidermal and liver lipids in db/db mice, we evaluated the 
expression of genes associated with lipid synthesis reported 
previously (Rabionet et al., 2014). Nuclear receptors related 
to lipid metabolism (LXR/β and PPAR) and lipid synthesizing 
enzymes [fatty acid synthase (FAS), elongases (Elovl1, 4 and 
6), and stearoyl-CoA desaturase (SCD)] were examined for 
their expression using qPCR. As shown in Fig. 5A and 5B, sig-
nificant increases in the expression of LXRβ, PPARγ, Elovl6, 
Elovl1, Elovl4, and SCD were noted in the skin of db/db mice 
compared with db/m mice, whereas LXRα/β, PPARγ, Elovl6, 
FAS, and SCD were significantly higher in the livers of db/db 
mice, indicating a profound change in both lipid metabolism 
and synthesis in both the skin and livers of db/db mice. 
DISCUSSION
In this study, we have demonstrated that db/db mice at the 
age of 20 weeks (representing longstanding, chronic hyper-
glycemia) exhibited reduced skin moisture and TEWL (Fig. 
1A-1E) compared to controls. Of note, ceramides and FFAs 
with medium chains were highly enriched in the skin epidermis 
of db/db mice, and those alteration patterns were repeated in 
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the liver (Fig. 3A, 3B), whereas in the kidney, the difference 
from db/m mice was markedly attenuated (Fig. 3C), suggest-
ing the existence of cross-talk in lipid synthesis and metabo-
lism between the epidermis and the liver.
In this study, we demonstrated that db/db mice show signifi-
cantly reduced skin hydration and TEWL compared to db/m 
mice (skin moisture, 3.6 ± 0.18 (n=10) vs. 13.6 ± 3.8 (n=5); 
TEWL 14.87 ± 0.5944 (n=10) vs. 30.82 ± 2.481 (n=5), t-test, 
p<0.05), indicating that epidermal homeostasis might be dis-
rupted in DM. Reduced skin hydration in DM has been dem-
onstrated in both DM patients (Sakai et al., 2005) and experi-
mental DM models [the Otsuka Long-Evans Tokushima Fatty 
(OLETF) rat (Park et al., 2011) and streptozotocin or alloxan-
induced DM (Sakai et al., 2003)], in line with our findings. In 
addition, Han and Park recently demonstrated that longstand-
ing hyperglycemia resulted in lower TEWL in the extremities 
of DM patients (Han and Park, 2017), further supporting our 
finding that longstanding DM can lead to impaired epidermal 
homeostasis.
Ceramides and FFAs with medium chains were enriched 
in the skin epidermis (Fig. 3A) of db/db mice, and those pat-
terns were similarly observed in the liver (Fig. 3B). Interesting-
ly, the alteration pattern of lipids in DM was distinct from that 
observed in skin affected by atopic dermatitis (AD), a repre-
sentative inflammatory dermatose with xerosis. In AD, asym-
metric alteration of ceramides across chain lengths was ob-
served, and ceramides with short chains (≤C22) increased in 
the epidermis, whereas ceramides with medium or long chains 
(≥C24) decreased significantly (Joo et al., 2015). Although the 
total amount of lipids in the epidermis of db/db mice increased, 
ceramides with short chains (≤C24) increased whereas ce-
ramides with long chains (>C24) were not significantly altered, 
resulting in a relative abundance of the shorter chains. The 
proper ratio and distribution of ceramides and FFAs across 
varying chain lengths, as well as their overall amounts, are im-
portant for maintaining epidermal homeostasis (Mojumdar et 
al., 2014) and skin barrier function (Oguri et al., 2014). Where-
as short-chain lipids are important for membrane fluidity, long-
chained ceramides have a higher stacking capacity and are 
pivotal in constructing a robust lamella structure (Ramos and 
Lafleur, 2015). The disproportionately high ratios of short ce-
ramides in DM could negatively affect the skin barrier function 
by tipping the balance of lipids toward shorter chains, leading 
to weaker stacking capacity and higher fluidity; however fur-
ther studies are needed to elucidate that finding.
In addition to hyperglycemia, DM causes dyslipidemia, al-
though its extent and patterns vary across tissues and with 
disease severity (Sas et al., 2016). Previously, it was shown 
that streptozotocin-induced DM led to increased phospholip-
ids and FFAs in the blood and livers of mice (Kumar et al., 
2013). Specifically, C18:1FA and ceramides with short chains 
were highly enriched in the liver. However, lipid profiles in the 
skin epidermis remain controversial. Sakai et al. (2003) report-
ed that streptozotocin-treated mice showed overall increases 
in ceramides and FFAs of the epidermis, whereas Park et al. 
demonstrated that the OLETF rat model exhibited reduced 
FFAs without changes in ceramides (Park et al., 2011), indi-
cating that physiological changes and ambient conditions af-
fect skin lipids. By using db/db mice at the age of 20 weeks to 
represent severe and chronic hyperglycemia, our study dem-
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onstrated that ceramides and FFAs with short chains might be 
disproportionately enriched in chronic hyperglycemia. 
Interestingly, the lipid profiles of both db/db and db/m mice 
were similar in the skin and livers of individual animals, sug-
gesting cross-talk between the skin and liver in lipid synthesis 
and metabolism. The PCA revealed a remarkable difference 
in the lipids of both the skin and the liver between db/db and 
db/m mice (Fig. 4A-4F). Of note, the lipids of marked distinc-
tion in both tissues largely overlapped, further supporting 
the close relationship between the skin and the liver in lipid 
synthesis. Indeed, the liver is known as a central organ for 
synthesizing and distributing lipids to peripheral tissues, and 
coordinated changes in certain lipids occur between the skin 
and the liver in disease states (Miyazaki et al., 2005). 
In addition, we demonstrated that the de novo synthesis 
of lipids in the skin in DM might be altered in the same pat-
tern seen in the liver. We found that molecules related to lipid 
metabolism and synthesis (LXRα (NR1H3), LXRβ (NR1H2), 
PPARγ, Elovl1, 4, and 6, FAS, and SCD) were upregulated 
in the skin and livers of db/db mice, suggesting that lipid syn-
thesis is stimulated both peripherally and centrally in db/db 
mice. LXRα/ play central roles in lipid metabolism and cho-
lesterol homeostasis, which regulate the expression of elon-
gases (Park et al., 2012), apolipoprotein E, and ATP-binding 
cassette protein A1 (Lee et al., 2013). Importantly, the role 
of LXRα/β has been suggested in skin diseases such as AD 
(Czarnowicki et al., 2018), psoriasis (Gupta et al., 2010), and 
vitiligo (Kumar et al., 2010), so the alteration of LXR might also 
be involved in DM skin disorders. PPARγ is critical to epider-
mal barrier function, regulating lipid uptake and adipogenesis 
as well as epidermal marker expression (Gupta et al., 2015). 
Indeed, dysregulation of LXR and PPARγ could be involved 
in abnormal epidermal homeostasis (Elias, 2005), and their 
activation promotes the expression of genes related to lipid 
synthesis and transport. Elongases are key to the synthesis 
of very long–chain fatty acids, mediating the condensation of 
acyl-CoA and malonyl-Coa to produce 3-ketoacyl-CoA (Jako-
bsson et al., 2006). FAS and SCD also play critical roles in the 
synthesis of fatty acids, producing a saturated fatty acid, pal-
mitic acid (C16:0), from acetyl-CoA and malonyl-CoA (Smith 
et al., 2003) and forming monounsaturated fatty acids (Paton 
and Ntambi, 2009) respectively. Elongases, FAS, and SCD 
also receive positive regulation from lipid metabolites and 
nuclear receptors, including LXR and PPARγ, which explains 
how their higher expression in db/db mice could contribute to 
the enrichment of lipids in the skin and liver. 
In conclusion, we have demonstrated that remarkable 
changes occur in the lipid profiles of the skin epidermis of db/
db mice, a Type 2 DM model, and that those changes coincide 
with changes in the liver and kidneys. The alteration of these 
lipids, which are critical to the normal homeostasis of the skin 
epidermis, could explain, at least in part, the abnormal skin 
barrier, hydration, and compromised defense against infection 
seen in DM patients. 
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